Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

Delayed Quote. Delayed  - 01/23 10:00:41 pm
6.9 USD   -4.43%
01/23 RITE AID : Ken Black Named Senior Vice President of Human Resources ..
01/21 RITE AID, WALGR : Report
01/20 FTC NOT SOLD ON : Bloomberg
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Rite Aid Corporation : Rite Aid Reports 2.9 Percent Same Store Sales Increase for April

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 01:10pm CET

Rite Aid Corporation (NYSE: RAD) today announced sales results for April.

Monthly Sales

For the four weeks ended April 28, 2012, same store sales increased 2.9 percent over the prior-year period. April front-end same store sales increased 2.7 percent. Pharmacy same store sales, which included an approximate 311 basis points negative impact from new generic introductions increased 3.0 percent. Prescription count at comparable stores increased 3.8 percent over the prior-year period.

Total drugstore sales for the four-week period increased 2.5 percent to $1.993 billion compared to $1.945 billion for the same period last year. Prescription sales accounted for 67.9 percent of drugstore sales, and third party prescription sales represented 96.6 percent of pharmacy sales.

Year-to-Date Sales

Same store sales for the eight-week period ended April 28, 2012 increased 3.3 percent, consisting of a 3.6 percent front-end same store sales increase and a 3.1 percent increase in pharmacy same store sales. Prescriptions filled at comparable stores increased 3.2 percent over the prior-year period.

Total drugstore sales for the eight weeks ended April 28, 2012 increased 2.8 percent to $3.982 billion from $3.875 billion in last year's like period. Prescription sales accounted for 68.5 percent of total drugstore sales, and third party prescription sales represented 96.7 percent of pharmacy sales.

Rite Aid is one of the nation's largest drugstore chains. On April 28, 2012, the company operated 4,658 stores compared to 4,705 stores in the like period a year ago. Information about Rite Aid, including corporate background and press releases, is available through the company's website at http://www.riteaid.com. Note that all sales data in this release is preliminary, unaudited and subject to revision.

Statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties that are described in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K and in other documents that we file or furnish with the Securities and Exchange Commission, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Rite Aid expressly disclaims any current intention to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise.

Rite Aid Corporation
Investors:
Matt Schroeder, 717-214-8867
investor@riteaid.com
or
Media:
Susan Henderson, 717-730-7766


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
01/23 RITE AID CORP : Change in Directors or Principal Officers (form 8-K)
01/23 RITE AID : Ken Black Named Senior Vice President of Human Resources and Chief Hu..
01/21 RITE AID, WALGREENS MERGER PLAN HASN : Report
01/20 FTC NOT SOLD ON WALGREENS' PLAN TO W : Bloomberg
01/17 LEBANON PUBLIC RECORD : Jan. 13 to Jan. 17
01/13 RITE AID : scammer can't dodge date with prison cell, U.S. judge rules
01/12 RITE AID'S DAYS NUMBERED AS WALGREEN : reports
01/12 RITE AID : Foundation Welcomes New Year with New Class of KidCents Charities
01/11 RITE AID : Irvington Police Warn Local Business Owners Of Phone Scam Involving C..
01/11 RITE AID : Shopping center that houses Rite Aid's operational headquarters and D..
More news
Sector news : Retail - Drugs without Grocery
01/20 FTC NOT SOLD ON WALGREENS' PLAN TO W : Bloomberg
01/19DJRival to EpiPen Allergy Treatment to Return to Market--Update
01/19DJRival to EpiPen Allergy Treatment to Return to Market
01/18DJMCKESSON : to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders --..
01/18DJMCKESSON : to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
01/23 Dissecting The Latest Rite Aid News
01/23 FTC threat still looms over Rite Aid and Fred's
01/20 After Hours Gainers / Losers
01/20 Drugstore investors scramble after FTC wildcard pops up
01/20 Midday Gainers / Losers
Advertisement
Financials ($)
Sales 2017 32 585 M
EBIT 2017 552 M
Net income 2017 69,1 M
Debt 2017 6 989 M
Yield 2017 -
P/E ratio 2017 115,00
P/E ratio 2018 62,73
Capi. / Sales 2017 0,44x
Capi. / Sales 2018 0,22x
Capitalization 7 261 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 8,88 $
Spread / Average Target 29%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & Chief Operating Officer
Darren W. Karst SEVP, Chief Financial & Administrative Officer
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-16.26%7 261
RAIA DROGASIL SA3.92%6 695
AIN HOLDINGS INC4.78%2 285
ORIOLA KD OYJ-0.23%840
AUSTRALIAN PHARMACEUTI..-2.91%734
ADCOCK INGRAM HOLDINGS..7.27%679
More Results